Elekta

Share Issue/Capital Change • Oct 31, 2007

NUMBER OF SHARES IN ELEKTA AS OF OCTOBER 31, 2007

PRESS RELEASE

Stockholm, Sweden, October 31, 2007

According to new legislation, all publicly listed companies must – if the number of shares has changed during the month – publish the total number of shares in the company on the last trading day of the month.

During October, 12,900 new B shares were issued in Elekta through the exercise of warrants distributed within the framework of the established option program.

The total number of shares in Elekta as of October 31, 2007 amounts to 93,892,990 divided between 3,562,500 A shares and 90,330,490 B shares.

Elekta's current holding of shares (treasury stock) amounts to 1,630,871 B shares, which the AGM on September 25, decided to cancel.

One Series A share entitles the holder to 10 votes and one Series B share to one vote.

******

For further information, please contact:

Okee Williams, Corporate Communications, Elekta AB Tel: +46 706 00 53 64 (mobile), e-mail: okee.williams@elekta.com

About Elekta

Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders.

Elekta's systems and solutions are used in over 4,500 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR and efficient management of clinical and patient data.

With over 2,000 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at www.elekta.com.